Sebastian Weigang

Freiburg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

The antiviral GTPase MxB is packaged into virions and binds via its N-terminal domain to alphaherpesvirus capsids.

The antiviral GTPase MxB is packaged into virions and binds via its N-terminal domain to alphaherpesvirus capsids.

Journal: PLoS pathogens
Published: October 08, 2025

SARS-CoV-2 Nsp1 Is a Major Suppressor of HLA Class I and Class II Expression.

SARS-CoV-2 Nsp1 Is a Major Suppressor of HLA Class I and Class II Expression.

Journal: Viruses
Published: June 27, 2025

Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient.

Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient.

Journal: Nature communications
Published: July 28, 2022

Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiency.

Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiency.

Journal: The journal of allergy and clinical immunology. In practice
Published: January 31, 2022

The interferon-inducible GTPase MxB promotes capsid disassembly and genome release of herpesviruses.

The interferon-inducible GTPase MxB promotes capsid disassembly and genome release of herpesviruses.

Journal: eLife
Published: January 05, 2022

Antibody escape and global spread of SARS-CoV-2 lineage A.27.

Antibody escape and global spread of SARS-CoV-2 lineage A.27.

Journal: Nature communications
Published: October 28, 2021

Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2.

Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2.

Journal: NPJ vaccines
Published: September 16, 2021

Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants.

Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants.

Journal: Nature communications
Published: April 23, 2021

Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.

Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.

Journal: JAMA pediatrics
Published: January 22, 2021

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

Journal: Science (New York, N.Y.)
Published: September 24, 2020

Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells.

Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells.

Journal: Cell reports. Medicine
Published: June 29, 2020

Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19.

Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19.

Journal: The Journal of allergy and clinical immunology
Published: June 04, 2020
Showing 1-12 of 15

Last Updated: 09/26/2026